Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Rutgers University Study of the Genetics of Blood Cancers

NCT07714044 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT07714044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07714044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Rutgers University Study of the Genetics of Blood Cancers
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Observational
Overall status
Recruiting
Start date
September 22, 2026
Completion date
August 31, 2029
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, blood cancers, hematologic cancer, hematologic malignancies, hematologic neoplasm, hematologic tumors, leukemia, lymphoma, myeloma